FDA Still Monitoring Safety Signal With Paclitaxel Stents in PAD FDA Still Monitoring Safety Signal With Paclitaxel Stents in PAD

The FDA continues to advise close monitoring of patients treated with paclitaxel-coated balloons and stents for PAD while investigation into potential safety concerns continues.News Alerts

Source: Medscape Radiology Headlines - December 3, 2021 Category: Radiology Tags: Cardiology News Source Type: news